Brief: Microbot Medical®’S Liberty® Endovascular Robotic System Is Now Adopted By Multiple Accounts Across Key Territories Including Two Access-Pvi Pivotal Clinical Trial Sites
05/05/2026 13:37
May 5 (Reuters) - Microbot Medical Inc MBOT.O: MICROBOT MEDICAL®’S LIBERTY® ENDOVASCULAR ROBOTIC SYSTEM IS NOW ADOPTED BY MULTIPLE ACCOUNTS ACROSS KEY TERRITORIES INCLUDING TWO ACCESS-PVI PIVOTAL CLINICAL TRIAL SITES Source text: ID:nGNX2TJQlV Further company coverage: MBOT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Microbot Medical
See all newsMicrobot Medical Inc expected to post a loss of 8 cents a share - Earnings Preview
Microbot Medical Inc reports results for the quarter ended June 30 - Earnings Summary
Microbot Medical Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Microbot Medical® Enters Into An Agreement To Expand Access For America’S Veteran And Military Patient Populations
Microbot Medical rises as U.S. federal supply deal expands reach of robotic surgical device